01 / 08
Arrow keys or space to navigate

Kyora

The vision

AI will solve problems humans cannot solve.

For success, it needs proprietary intelligence
at scale.

The focus

Kyora targets IP that generates unique intelligence and a product opportunity.

The Ideal: held companies have two revenue categories.

THE IDEAL

Therefore, held companies have two revenue categories.

Products and compounding intelligence.

PRODUCT REVENUE

Product sales

License fees

Royalty income

Milestone payments

Distribution revenue

COMPOUNDING INTELLIGENCE REVENUE

Data licensing

Model-training access

Analytics subscriptions

API usage fees

Partner-funded programs

The Strategy

Kyora moves breakthru science from research IP to exit with a 5 step strategy.

The Funnel

Major investment curated the science and recruited the talent.

This was not organic. Knight-backed investment helped concentrate world-class science and talent across UO and OHSU.

Sources: UO Knight Campus, 2021; UO Knight Campus funding notes; OHSU News, Aug. 14, 2025. No partnership implied.06
Seismic Shift: AI biointelligence expands market capture.

SEISMIC SHIFT

AI biointelligence expands market capture.

More biology becomes solvable.

More companies become operable.

More value becomes captured.

TAM

Broad AI-bio universe.

SAM

AI-bio and data wedge.

SOM

Illustrative 10-year Kyora platform capture case.

Summary: Kyora outcome and key assumptions.

SUMMARY

Kyora outcome: Private equity-like ownership. Venture capital-like upside.

1

AI will solve problems humans cannot solve alone. The future is rapid commercialization of solutions to problems previously out of reach.

2

This data will generate massive new revenues through new productization and model training.

3

Oregon has a concentration of untapped potential human health solutions from a ~$3B Knight investment.

4

A strong operationalizing model is missing from the Oregon ecosystem. Kyora fills this gap.

5

Kyora held companies will bring new levels of improved health to humanity.

6

Kyora expands what is solvable, operable, and the total captured revenue.

Scroll

Kyora

AI-Neuro-Bio Ecosystem

New Capabilities for Humanity.
New Categories of Business.

Powered by unique experimental capacities, foundational data modalities, and advanced manufacturing. By leveraging an unusually strong talent and infrastructure base, we have assembled a combination of IP that pushes into frontiers of human potential previously thought impossible.

Get in Touch Explore Capabilities

Scroll

Four Foundational Pillars Powering the Next Generation of Innovation

01 Neuro Data

Longitudinal, High-Resolution Human Brain Data Platforms

Human brain data remains one of the least explored yet highest-value datasets available.

We've developed thin-film implant technologies and advanced manufacturing materials that enable in-body neural interface devices with unprecedented resolution and longevity.

Unlike short-term or low-density systems, this platform enables longitudinal human brain data collection, opening an untapped frontier in neuroscience, neuromodulation, and AI training.

Resolution

High

Sample Rate

Continuous

Application

Diagnostic
02 Evo Data

Animal Directed Evolution + AI

Directed evolution hasn't been deployed for human conditions like aging that require the context of an aging body.

We've developed technology that allows us to perform directed evolution in animal models to generate novel peptides with therapeutic activity grounded on in vivo data, at an unrivaled scale.

By tightly coupling this biological data with AI, we are building a system that can dramatically accelerate peptide engineering, moving from simulation toward AI-biological feedback loops.

Data

At Scale

Approach

In Vivo

Application

Novel Peptides
03 In Silico Data

A First-of-Its-Kind AI Bioengineering Lab

The ability to model 3D protein structures is revolutionizing protein engineering.

We are starting a bio-engineering company founded around an extremely practical product that was engineered using AI. This product could not exist without the ability to engineer peptides through AI-driven methods.

Using early revenue, we plan to tap directly into a growing pipeline of bioengineering PhDs and technical talent from the Knight Campus, capturing creativity for continued product innovation.

Revenue

Near-Term

Pipeline

Quant Bio

Application

New Products
04 Advanced Manufacturing and Materials

Scaling stronger, lighter, higher

New advanced materials, sensor systems, controls, fuels, and manufacturing techniques toward repeatable, production-ready capacity.

Our capability supports faster iteration across materials, sensors, controls, and manufacturing techniques while shortening R&D and commercialization timelines.

Cleanroom

Class 1

Production

Advanced

Availability

Near-Term

Exceptional Founders.
Deep Technical Leadership.
Disciplined Execution.

Explore the future together, contact us